Table: begin end state 1 92 cytoplasmic 93 110 transmembrane 111 129 non-cytoplasmic 130 152 transmembrane 153 174 cytoplasmic 175 193 transmembrane 194 204 non-cytoplasmic 205 224 transmembrane 225 228 cytoplasmic 229 248 transmembrane 249 256 non-cytoplasmic 257 279 transmembrane 280 286 cytoplasmic 287 304 transmembrane 305 340 non-cytoplasmic 341 359 transmembrane 360 389 cytoplasmic 390 409 transmembrane 410 421 non-cytoplasmic 422 453 transmembrane 454 464 cytoplasmic 465 483 transmembrane 484 515 non-cytoplasmic
Input: >WP_041938756.1 NCBI__GCF_000058485.1:WP_041938756.1 MSTPPPAGPPGPPDPAGPGSGAATMPLRVAGSRSGPSGSAAPGASADSLARADPLAPADP VGHGGPSGPGPGGGPGLPAWHPAVLFAPARLRQLGALLLVGVLAAIVTGPTGNSDKPLQA AKDSIVDVRIVLYLGLAAALWVLLVLGAELRGALERLSAPVRAPIGAAYGRRGGPIVLNL VLLAVAILAPLVVSTAAQQSMVNDIGIYALLALGLNVVVGYAGLLDLGYIAFFAIGAYAT AYFTSQTAMPWHAPFVLNPFFVFPIALVLAALAGVILGAPTLRLRGDYLAIVTLGFGEII HLVANNADGITNGARGAFGVPHLSIDLLGIDYKWGIDPLPYYYLLLAIVIGVMIAFGRLE RSRIGRSWAAIREDEIAAEATGVATLRMKLLAFAIGASVSGFAGVLFASKQFFNPQSFSL QASFFVVAVVIFGGMGSRLGVVVGAVVLQGLAFYLRDKVQPADRYIYFGAVIVIMMIFRP QGLVPSRRRRREIELAEEGIGAADSLGAAPTGGHR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server